# Janux Therapeutics, Inc.: filings

JANX · Nasdaq · CIK 1817713 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/janx.md) · [Financials](/companies/janx/financials.md) · [Filings](/companies/janx/filings.md) · [Insiders](/companies/janx/insiders.md)

## Reports and events: 93 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 136, 144 87, 8-K 49, 3 27, 10-Q 16, SC 13G/A 14, SC 13D/A 12, SCHEDULE 13G/A 12, SC 13G 8, 424B5 6, DEFA14A 6, S-8 6, 10-K 5, CORRESP 5, DEF 14A 5, SCHEDULE 13G 5, 144/A 4, ARS 4, D 3, SC 13D 3, SEC STAFF LETTER 3, UPLOAD 3, 4/A 2, EFFECT 2, FWP 2, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, S-1 1, S-1/A 1, S-1MEF 1, S-3 1, S-3ASR 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:18 ET | [10-Q](/filings/0001193125-26-338078.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338078 |
| 2026-08-06 | 16:08 ET | [8-K](/filings/0001193125-26-337977.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337977 |
| 2026-06-23 | 16:05 ET | [8-K](/filings/0001193125-26-279428.md) | 8.01 Other events | 0001193125-26-279428 |
| 2026-06-12 | 16:06 ET | [8-K](/filings/0001193125-26-269387.md) | 5.07 Shareholder vote results | 0001193125-26-269387 |
| 2026-05-07 | 16:33 ET | [10-Q](/filings/0001193125-26-212146.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212146 |
| 2026-05-07 | 16:16 ET | [8-K](/filings/0001193125-26-211964.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211964 |
| 2026-04-28 | 17:02 ET | [8-K](/filings/0001193125-26-187641.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-187641 |
| 2026-04-28 | 16:15 ET | [DEF 14A](/filings/0001193125-26-187095.md) | Proxy statement, period 2026-06-11 | 0001193125-26-187095 |
| 2026-02-26 | 16:32 ET | [10-K](/filings/0001193125-26-076918.md) | Annual report, period 2025-12-31 | 0001193125-26-076918 |
| 2026-02-26 | 16:10 ET | [8-K](/filings/0001193125-26-076627.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076627 |
| 2026-01-22 | 16:30 ET | [8-K](/filings/0001193125-26-019520.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-019520 |
| 2025-11-06 | 16:39 ET | [10-Q](/filings/0001193125-25-269799.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269799 |
| 2025-11-06 | 16:10 ET | [8-K](/filings/0001193125-25-269518.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269518 |
| 2025-09-19 | 17:06 ET | [8-K](/filings/0001193125-25-209259.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-209259 |
| 2025-08-07 | 16:22 ET | [10-Q](/filings/0000950170-25-105069.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105069 |
| 2025-08-07 | 16:08 ET | [8-K](/filings/0000950170-25-105010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105010 |
| 2025-06-13 | 16:35 ET | [8-K](/filings/0000950170-25-086284.md) | 5.07 Shareholder vote results | 0000950170-25-086284 |
| 2025-05-08 | 16:30 ET | [10-Q](/filings/0000950170-25-067083.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067083 |
| 2025-05-08 | 16:12 ET | [8-K](/filings/0000950170-25-066969.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066969 |
| 2025-04-25 | 16:39 ET | [DEF 14A](/filings/0000950170-25-058806.md) | Proxy statement, period 2025-04-25 | 0000950170-25-058806 |
| 2025-03-10 | 16:33 ET | [SCHEDULE 13D/A](/filings/0001415889-25-007529.md) | Ownership report, active investor, amended | 0001415889-25-007529 |
| 2025-02-27 | 16:53 ET | [10-K](/filings/0000950170-25-029177.md) | Annual report, period 2024-12-31 | 0000950170-25-029177 |
| 2025-02-27 | 16:49 ET | [8-K](/filings/0000950170-25-029165.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-029165 |
| 2024-12-05 | 16:32 ET | [8-K](/filings/0001193125-24-271578.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-271578 |
| 2024-12-02 | 17:10 ET | [8-K](/filings/0000950170-24-132302.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-132302 |
| 2024-11-08 | 17:58 ET | [SC 13D/A](/filings/0001104659-24-116001.md) | Ownership report, active investor, amended | 0001104659-24-116001 |
| 2024-11-06 | 16:23 ET | [10-Q](/filings/0000950170-24-122370.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122370 |
| 2024-11-06 | 16:07 ET | [8-K](/filings/0000950170-24-122279.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122279 |
| 2024-10-25 | 17:28 ET | [SC 13D/A](/filings/0001104659-24-111544.md) | Ownership report, active investor, amended | 0001104659-24-111544 |
| 2024-10-22 | 16:17 ET | [SC 13D/A](/filings/0001104659-24-110569.md) | Ownership report, active investor, amended | 0001104659-24-110569 |
| 2024-10-22 | 16:16 ET | [SC 13D/A](/filings/0001104659-24-110567.md) | Ownership report, active investor, amended | 0001104659-24-110567 |
| 2024-09-16 | 21:41 ET | [SC 13D/A](/filings/0001104659-24-100347.md) | Ownership report, active investor, amended | 0001104659-24-100347 |
| 2024-09-16 | 21:35 ET | [SC 13D/A](/filings/0001104659-24-100346.md) | Ownership report, active investor, amended | 0001104659-24-100346 |
| 2024-08-09 | 16:09 ET | [SC 13D/A](/filings/0000947871-24-000668.md) | Ownership report, active investor, amended | 0000947871-24-000668 |
| 2024-08-07 | 16:28 ET | [10-Q](/filings/0000950170-24-092857.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092857 |
| 2024-08-07 | 16:20 ET | [8-K](/filings/0000950170-24-092830.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092830 |
| 2024-07-22 | 17:00 ET | [8-K](/filings/0000950170-24-085321.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-085321 |
| 2024-06-28 | 16:12 ET | [8-K](/filings/0000950170-24-079059.md) | 5.07 Shareholder vote results | 0000950170-24-079059 |
| 2024-06-05 | 19:28 ET | [SC 13D/A](/filings/0001104659-24-068766.md) | Ownership report, active investor, amended | 0001104659-24-068766 |
| 2024-05-08 | 20:14 ET | [10-Q](/filings/0000950170-24-054966.md) | Quarterly report, period 2024-03-31 | 0000950170-24-054966 |
| 2024-05-08 | 20:05 ET | [8-K](/filings/0000950170-24-054950.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-054950 |
| 2024-04-29 | 16:16 ET | [DEF 14A](/filings/0000950170-24-049873.md) | Proxy statement, period 2024-06-26 | 0000950170-24-049873 |
| 2024-03-08 | 16:23 ET | [10-K](/filings/0000950170-24-028659.md) | Annual report, period 2023-12-31 | 0000950170-24-028659 |
| 2024-03-08 | 16:11 ET | [8-K](/filings/0000950170-24-028647.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-028647 |
| 2024-03-06 | 18:54 ET | [SC 13D/A](/filings/0001104659-24-031587.md) | Ownership report, active investor, amended | 0001104659-24-031587 |
| 2024-03-04 | 20:07 ET | [SC 13D/A](/filings/0001104659-24-030638.md) | Ownership report, active investor, amended | 0001104659-24-030638 |
| 2024-02-29 | 17:11 ET | [8-K](/filings/0000950170-24-023257.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-023257 |
| 2024-02-28 | 17:15 ET | [8-K](/filings/0000950170-24-022266.md) | 8.01 Other events | 0000950170-24-022266 |
| 2024-02-27 | 17:23 ET | [8-K](/filings/0000950170-24-021425.md) | 8.01 Other events | 0000950170-24-021425 |
| 2024-02-26 | 16:23 ET | [8-K](/filings/0000950170-24-020183.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-020183 |

Page 1 of 2. [Older](/companies/janx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.